DermTech Inc (NASDAQ: DMTK) is -59.89% lower on its value in year-to-date trading and has touched a low of $0.62 and a high of $4.67 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DMTK stock was last observed hovering at around $0.71 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.70, the stock is -5.64% and -33.93% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing -0.99% at the moment leaves the stock -60.39% off its SMA200. DMTK registered -79.04% loss for a year compared to 6-month loss of -54.12%. The firm has a 50-day simple moving average (SMA 50) of $1.49 and a 200-day simple moving average (SMA200) of -$0.23.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -47.22% gain in the last 1 month and extending the period to 3 months gives it a -62.66%, and is -1.40% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.56% over the week and 11.09% over the month.
DermTech Inc (DMTK) has around 208 employees, a market worth around $24.30M and $15.30M in sales. Profit margin for the company is -659.57%. Distance from 52-week low is 12.70% and -84.97% from its 52-week high. The company has generated returns on investments over the last 12 months (-93.00%).
DermTech Inc quarterly earnings per share for the current quarter are estimated at -$0.57 with sales reaching $3.96M over the same period.The EPS is expected to grow by 35.55% this year, but quarterly earnings will post 15.60% year-over-year. Quarterly sales are estimated to grow 13.90% in year-over-year returns.
91 institutions hold shares in DermTech Inc (DMTK), with institutional investors hold 22.20% of the company’s shares. The shares outstanding are 34.52M, and float is at 30.61M with Short Float at 10.27%. Institutions hold 21.26% of the Float.
The top institutional shareholder in the company is RTW Investments LP with over 2.72 million shares valued at $7.07 million. The investor’s holdings represent 8.07% of the DMTK Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 1.21 million shares valued at $3.14 million to account for 3.58% of the shares outstanding. The other top investors are Blackrock Inc. which holds 0.44 million shares representing 1.30% and valued at over $1.14 million, while Triatomic Management Lp holds 1.19% of the shares totaling 0.4 million with a market value of $1.04 million.
DermTech Inc (DMTK) Insider Activity
The most recent transaction is an insider sale by Sun Kevin M, the company’s Chief Financial Officer. SEC filings show that Sun Kevin M sold 447 shares of the company’s common stock on Dec 11 ’23 at a price of $1.45 per share for a total of $648.0. Following the sale, the insider now owns 0.28 million shares.
DermTech Inc disclosed in a document filed with the SEC on Dec 11 ’23 that Ibarra Claudia (Chief Operating Officer) sold a total of 331 shares of the company’s common stock. The trade occurred on Dec 11 ’23 and was made at $1.45 per share for $480.0. Following the transaction, the insider now directly holds 0.19 million shares of the DMTK stock.
Still, SEC filings show that on Dec 08 ’23, Ibarra Claudia (Chief Operating Officer) disposed off 2,607 shares at an average price of $1.41 for $3676.0. The insider now directly holds 193,878 shares of DermTech Inc (DMTK).
